Skip Navigation


Carcinogenesis Advance Access originally published online on January 6, 2009
Carcinogenesis 2009 30(2):258-268; doi:10.1093/carcin/bgn284
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
30/2/258    most recent
bgn284v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tan, T.-W.
Right arrow Articles by Tang, C.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tan, T.-W.
Right arrow Articles by Tang, C.-H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Cyr61 increases migration and MMP-13 expression via {alpha}vβ3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells

Tzu-Wei Tan1,2,{dagger}, Wei-Hung Yang3,4,5,{dagger}, Yuh-Tzy Lin6, Sheng-Feng Hsu7, Te-Mao Li7, Shung-Te Kao8, Wen-Chi Chen9, Yi-Chin Fong5,8,10 and Chih-Hsin Tang1,2,*

1 Department of Pharmacology, College of Medicine, China Medical University, No. 91, Hsueh-Shih Road, Taichung 404, Taiwan
2 Graduate Institute of Basic Medical Science, China Medical University, Taichung 404, Taiwan
3 Graduate Institute of Biotechnology, National Chung Hsing University, Taichung 402, Taiwan
4 Department of Orthopaedic Surgery, China Medical University Beigang Hospital, Yun-Lin County 651, Taiwan
5 School of Chinese Medicine, China Medical University, Taichung 404, Taiwan
6 Department of Nursing and Management, Jen-Teh Junior College of Medicine, Miaoli County 305, Taiwan
7 Graduate Institute of Acupuncture Science
8 Graduate Institute of Chinese Medical Science
9 Graduate Institute of Integrated Medicine, China Medical University, Taichung 404, Taiwan
10 Department of Orthopaedics, China Medical University Hospital, Taichung 404, Taiwan

* To whom correspondence should be addressed. Tel: +886 4 22053366 ext. 2228; Fax: +886 4 22053764; Email: chtang{at}mail.cmu.edu.tw

Correspondence may also be addressed to Yi-Chin Fong. Tel: +886 4 22062121 ext. 2073; Fax: +886 4 22038316; Email: yichin.fong{at}mail.cmu.edu.tw

Cysteine-rich 61 (Cyr61), from the CCN gene family, is a secreted and matrix-associated protein, which is involved in many cellular activities such as growth and differentiation. However, the effect of Cyr61 on migration activity in human chondrosarcoma cells is mostly unknown. Here, we found that Cyr61 increased the migration and expression of matrix metalloproteinase (MMP)-13 in human chondrosarcoma cells (JJ012 cells). RGD peptide, {alpha}vβ3 monoclonal antibody and mitogen-activated protein kinase (MEK) inhibitors (PD98059 and U0126) but not RAD peptide inhibited the Cyr61-induced increase of the migration and MMP-13 upregulation of chondrosarcoma cells. Cyr61 stimulation increased the phosphorylation of focal adhesion kinase (FAK) and extracellular signal-regulated kinase (ERK). In addition, activator protein-1 (AP-1) decoy oligodeoxynucleotide also suppressed the MMP-13 messenger RNA and enzyme activity enhanced by Cyr61. Moreover, Cyr61 increased the binding of c-Fos and c-Jun to the AP-1 element on the MMP-13 promoter. Taken together, our results indicated that Cyr61 enhances the migration of chondrosarcoma cells by increasing MMP-13 expression through the {alpha}vβ3 integrin receptor, FAK, ERK, c-Fos/c-Jun and AP-1 signal transduction pathway.

Abbreviations: AP-1, activator protein-1; AS, antisense; Cyr61, cysteine-rich 61; ECM, extracellular matrix; ERK, extracellular signal-regulated kinase; FAK, focal adhesion kinase; mAb, monoclonal antibody; MEK, MAPK kinase; MMP, matrix metalloproteinase; mRNA, messenger RNA; MS, missense; NF-{kappa}B, nuclear factor-kappa B; ODN, oligonucleotide; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; qPCR, quantitative real-time polymerase chain reaction; siRNA, small-interfering RNA


{dagger} These authors contributed equally to this work.

Received July 22, 2008; revised November 5, 2008; accepted December 9, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.